DUCA, LEONARDO

DUCA, LEONARDO  

Dipartimento di Medicina Sperimentale  

Mostra records
Risultati 1 - 16 di 16 (tempo di esecuzione: 0.027 secondi).
Data di pubblicazione Titolo Autore(i) Tipo File
1-mar-2024 Evaluation of HIV-1 DNA levels among adolescents living with perinatally acquired HIV-1 in Yaounde, Cameroon: A contribution to paediatric HIV cure research in Sub-Saharan Africa Ka'E, Ac; Santoro, M; Duca, L; Chenwi, Ca; Ngoufack Jagni Semengue, E; Nka, Ad; Etame, N; Togna Pabo, Wl; Beloumou, G; Mpouel, Ml; Djupsa, S; Takou, D; Sosso, Sm; Tchidjou, Hk; Colizzi, V; Halle-Ekane, G; Perno, C; Lewin, S; Jones, Rb; Tiemessen, Ct; Ceccherini-Silberstein, F; Fokam, J Articolo su rivista
1-gen-2023 Frequency of atypical mutations in the spike glycoprotein in SARS-CoV-2 circulating from July 2020 to July 2022 in central Italy: a refined analysis by Next Generation Sequencing Bellocchi, Mc; Scutari, R; Carioti, L; Iannetta, M; Marchegiani, G; Piermatteo, L; Coppola, L; Tedde, S; Duca, L; Malagnino, V; Ansaldo, L; Braccialarghe, N; D′Anna, S; Mercedes Santoro, M; DI LORENZO, A; Salpini, R; Teti, E; Svicher, V; Andreoni, M; Sarmati, L; Ceccherini-Silberstein, F Articolo su rivista
1-mar-2023 HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli Salpini, R; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini Silberstein, F; Sarmati, L; V. Svicher., Intervento a convegno
1-gen-2023 HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL R, S; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher., V Intervento a convegno
1-gen-2023 HDV replicative activity parallels the production of the three HBsAg forms (Large, Middle and Small HBsAg) and its pathogenetic impact is exacerbated by concomitant HBV replication Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R Intervento a convegno
1-gen-2023 Higher levels of three HBsAg forms (Large, Middle and Small HBsAg) are associated with HDV replication and with the degree of disease and liver damage. Duca, L; Olivero, A; Piermatteo, L; D’Anna, S; Torre, G; Teti, E; DI LORENZO, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; CECCHERINI SILBERSTEIN, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Rizzetto, M; Paolo Caviglia, G; Svicher, V; Salpini, R Intervento a convegno
1-gen-2023 HIV DNA viral reservoirs in blood and gut-associated lymphoid tissues (GALT): Implications of switch from triple antiretroviral therapy (ART) to 2-drug dolutegravir/lamivudine regimens Chenwi, Ca; Compagno, M; Benedetti, L; Duca, L; Matteucci, C; Ka'E, Ac; Piermatteo, L; Scutari, R; Khan, S; El Khalili, O; Ferrari, L; Malagnino, V; Teti, E; Bertoli, A; Salpini, R; Grelli, S; Iannetta, M; Sarmati, L; Andreoni, M; CECCHERINI SILBERSTEIN, F Intervento a convegno
1-gen-2023 Kinetics of HBsAg forms in chronic hepatitis delta patients treated with bulevirtide for 48 weeks: correlation with virological response D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V Intervento a convegno
1-gen-2023 Kinetics of the Three HBsAg Isoforms along with HDV-RNA Predict Virological Response in CHD Patients Treated with Bulevirtide for 48 Weeks D'Anna, S; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher, V Intervento a convegno
1-gen-2023 KINETICS OF THE THREE HBSAG ISOFORMS ALONG WITH HDV-RNA PREDICT VIROLOGICAL RESPONSE IN CHD PATIENTS TREATED WITH BULEVIRTIDE UP TO 96 WEEKS P 215 D’Anna, ; Salpini, R; Degasperi, E; Duca, L; Anolli, Mp; Piermatteo, L; Sambarino, D; Borghi, M; Facchetti, F; Ceccherini-Silberstein, F; Perbellini, R; Lampertico, P; Svicher., V Intervento a convegno
1-set-2023 Long-acting combination of cabotegravir plus rilpivirine: A picture of potential eligible and ineligible HIV-positive individuals from the Italian ARCA cohort Cervo, A; Russo, A; Di Carlo, D; De Vito, A; Fabeni, L; D'Anna, S; Duca, L; Colpani, A; Fois, M; Zauli, B; Mancarella, G; Carraro, A; Bezenchek, A; Cozzi-Lepri, A; Santoro, M Articolo su rivista
1-gen-2024 Prevalence of HDV infection in Central Italy has remained stable across the last two decades with dominance of sub-genotypes 1 and characterized by elevated viral replication Salpini, R; Piermatteo, L; Torre, G; D'Anna, S; Khan, S; Duca, L; Bertoli, A; La Frazia, S; Malagnino, V; Teti, E; Iannetta, M; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Pellicelli, A; Galati, G; Moretti, A; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Marignani, M; Ceccherini-Silberstein, F; Baiocchi, L; Grelli, S; Sarmati, L; Svicher, V Articolo su rivista
1-gen-2023 Stable temporal trend of HDV seroprevalence in central Italy across the last two decades with the circulation of HDV sub-genotypes 1 inducing different inflammatory stimuli Piermatteo, L; Salpini, R; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher, V Intervento a convegno
1-gen-2023 ULTRASENSITIVE HBV-RNA QUANTIFICATION AS A PROMISING BIOMARKER TO OPTIMIZE THE STAGING OF CHRONIC HBV INFECTION AND TO DETECT MINIMAL VIRAL ACTIVITY UNDER PROLONGED VIROLOGICAL SUPPRESSION AND OCCULT HBV INFECTION. Piermatteo, L; D’Anna, S; Duca, L; Torre, G; Guerra, Af; Boarini, C; Tavelli, A; Ventura, P; Ceccherini-Silberstein, F; Pietrangelo, A; D’Arminio Monforte, A; Abbati, G; Gill, U; Kennedy, P; Svicher, V; Salpini Oral presentation at the, R; Bari, M; 14-16 June, 2 Intervento a convegno
1-gen-2023 Ultrasensitive HBV-RNA quantification by droplet digital PCR is a promising biomarker to optimize the staging of chronic HBV infection and to identify minimal viral activity under prolonged virological suppression. Salpini, R; Piermatteo, L; D’Anna, S; Duca, L; Torre, G; Guerra, Af; Boarini, C; Tavelli, A; Ventura, P; Ceccherini Silberstein, F; Pietrangelo, A; Puoti, M; D’Arminio Monforte, A; Abbati, G; Gill, U; Kennedy, P; Svicher, V Intervento a convegno
15-lug-2024 Use of next-generation sequencing on HIV-1 DNA to assess archived resistance in highly treatment-experienced people with multidrug-resistant HIV under virological control: data from the PRESTIGIO Registry Armenia, D; Spagnuolo, V; Bellocchi, Mc; Galli, L; Duca, L; Marchegiani, G; Clemente, T; Carioti, L; Lolatto, R; Calza, L; Celesia, Bm; Cascio, A; Francisci, D; Saracino, A; Torti, C; Zazzi, M; Castagna, A; Santoro, M Articolo su rivista